First Commercially Available CD137 Antibody in Next 6 to 7 Years

DUBLIN, June 7, 2023 /PRNewswire/ — The “Global CD137 Antibodies Clinical Trials & Market Trends Insight 2023” report has been added to ResearchAndMarkets.com’s offering. The therapeutic potential of CD137 has been investigated exhaustively and has now been confirmed as studies from running clinical and research studies emerge. Many companies are now developing agonists against this receptor … Read more

Die HARMONY Alliance soll zu einer Forschungsstiftung werden

Die HARMONY Alliance hat den Einsatz von Big Data in der Blutkrebs-Forschung revolutioniert.  Hin zu einer gemeinnützigen Forschungsstiftung.  Hämatologie-Forschung und Patientenversorgung auf ein höheres Niveau bringen.  DEN HAAG, Niederlande, 7. Juni 2023 /PRNewswire/ — Die HARMONY Alliance hat die Nutzung von Big Data revolutioniert, um die Entwicklungen bei der Behandlung von Patienten mit Blutkrebs zu … Read more

The HARMONY Alliance is set to become a research foundation

The HARMONY Alliance has revolutionized the use of big data in Hematologic Malignancies research. Becoming a non-profit research foundation. Bringing hematology research and patient care to the next level. THE HAGUE, Netherlands, June 7, 2023 /PRNewswire/ — The HARMONY Alliance has revolutionized the use of big data to accelerate developments in treating patients with Hematological … Read more

Google Cloud Collaborates with Mayo Clinic to Transform Healthcare with Generative AI

From reimagining enterprise search, to future programs that will transform patient care and research, Google Cloud is putting this new category of artificial intelligence to work for healthcare SUNNYVALE, Calif., June 7, 2023 /PRNewswire/ — Google Cloud today announced a collaboration with Mayo Clinic to transform healthcare with generative AI, starting with Enterprise Search in … Read more

CaringBridge Invites the World to Help Solve Loneliness and Isolation

Join the Global Celebration of Family Caregiver Support, Share Your Story, and Make a Difference on June 7 EAGAN, Minn., June 7, 2023 /PRNewswire/ — In a world where 40% of unpaid caregivers report feeling isolated and unsupported, CaringBridge, a non-profit, no cost communication platform for family caregivers and the loved ones they support on … Read more

Dizal Leads China’s Biotech Innovation by Showcasing Strength of its Oncology Pipeline at 2023 ASCO

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidocitinib (JACKPOT8) Sunvozertinib achieved an ORR of 60.8% in ≥ second-line treatment and 77.8% in the first-line treatment for EGFR Exon20ins NSCLC Sunvozertinib demonstrated durable benefit in advanced NSCLC patients with TKI-resistant EGFR sensitizing mutations with a … Read more

Resitu Medical AB’s Stefan Sowa Wins Two Business Worldwide Magazine CEO Awards

LONDON, June 7, 2023 /PRNewswire/ — Business Worldwide Magazine has twice honoured the CEO of Resitu Medical AB. Stefan Sowa received two accolades at the 2023 CEO Awards: “Healthcare CEO of the Year – Sweden“ and “Most Innovative CEO in the Medical Device Industry – Europe.” The CEO Awards seek to identify and honour the most … Read more

ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization

BASEL, Switzerland, June 7, 2023 /PRNewswire/ — Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies is no easy feat.  To support the commercialization of cell therapies, ACROBiosystems is now offering a global custom GMP-grade … Read more